Prosecution Insights
Last updated: August 17, 2026
Application No. 18/025,378

PPG CONTROL METHOD AND APPARATUS, AND ELECTRONIC DEVICE

Non-Final OA §102§103
Filed
Mar 08, 2023
Priority
Dec 30, 2021 — CN 202111654810.5 +2 more
Examiner
MUSTANSIR, ABID A
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Honor Device Co., Ltd.
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
364 granted / 465 resolved
+8.3% vs TC avg
Moderate +12% lift
Without
With
+11.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
22 currently pending
Career history
513
Total Applications
across all art units

Statute-Specific Performance

§101
6.8%
-33.2% vs TC avg
§103
42.2%
+2.2% vs TC avg
§102
24.2%
-15.8% vs TC avg
§112
21.0%
-19.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 465 resolved cases

Office Action

§102 §103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The action is in response to the application filed on 03/08/2023. Election/Restrictions Applicant has amended the claims such that the Requirement for Restriction/Election dated 12/09/2025 are moot. Claims 1-10, 12-21 are pending and examined below. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 7, 12, and 13 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 20140323828 A1 (hereinafter referred to as “Ahmed”). Regarding claim 1, Ahmed teaches a photoplethysmography (PPG) control method, wherein the method is applied to an electronic device, the electronic device comprises a PPG module, the PPG module comprises a light emitting module (“a wearable physiological measurement system includes a plurality of light emitters”; paragraph [0012]; Figure 6), and the method comprises: determining a current measurement environment and/or measurement target (“determine a motion status of the user”; paragraph [0012]; Figure 6), wherein the measurement environment comprises at least one of motion, rest, and sleep (“exercise, light motion (e.g., walking), no motion or rest, sleep”; paragraph [0124]; Figure 6), and the measurement target comprises at least one of a heart rate and blood oxygen (“determine a heart rate of the user”; paragraph [0012]; Figure 6), and determining a light emitting mode of the light emitting module based on the current measurement environment and/or measurement target (“based on the motion status of the user, automatically and selectively activate one or more of the light emitters to determine a heart rate of the user”; paragraph [0012]; “The processing module may adjust the duty cycle of one or more light emitters and the corresponding sampling rate of the one or more light detectors based on the motion status. For example, upon determining that the motion status indicates that the user is at a first higher level of motion, the processing module may activate the light emitters at a first higher duty cycle and sample the reflected light using light detectors sampling at a first higher sampling rate”; paragraph [0125]; Figure 6). Regarding claim 7, Ahmed further teaches determining a sampling rate of the PPG module based on the current measurement environment (“adjust the duty cycle of one or more light emitters and the corresponding sampling rate”; paragraph [0125]; Figure 6), using a first sampling rate when the measurement environment is motion (“sampling at a first higher sampling rate”; paragraph [0125]; Figure 6), or using a second sampling rate when the measurement environment is rest or sleep (“sampling at a second lower sampling rate”; paragraph [0126]; Figure 6), wherein the first sampling rate is greater than the second sampling rate (“the second sampling rate is lower than the first sampling rate”; paragraph [0126]; Figure 6). Regarding claim 12, Ahmed teaches an electronic device (“a wearable physiological measurement system”; paragraph [0012]; Figure 6), wherein the electronic device comprises a memory configured to store a computer program instruction (“one or more non-transitory computer-readable media”; paragraph [0014]; Figure 6), and a processor configured to execute a computer program instruction (“a processing module configured to”; paragraph [0012]; Figure 6), and when the computer program instruction is executed by the processor, the electronic device is triggered to perform operations of determining a current measurement environment and/or measurement target (“determine a motion status of the user”; paragraph [0012]; Figure 6), wherein the measurement environment comprises at least one of motion, rest, and sleep (“exercise, light motion (e.g., walking), no motion or rest, sleep”; paragraph [0124]; Figure 6), and the measurement target comprises at least one of a heart rate and blood oxygen (“determine a heart rate of the user”; paragraph [0012]; Figure 6), and determining a light emitting mode of the light emitting module based on the current measurement environment and/or measurement target (“based on the motion status of the user, automatically and selectively activate one or more of the light emitters to determine a heart rate of the user”; paragraph [0012]; “The processing module may adjust the duty cycle of one or more light emitters and the corresponding sampling rate of the one or more light detectors based on the motion status. For example, upon determining that the motion status indicates that the user is at a first higher level of motion, the processing module may activate the light emitters at a first higher duty cycle and sample the reflected light using light detectors sampling at a first higher sampling rate”; paragraph [0125]; Figure 6). Regarding claim 13, Ahmed teaches a non-transitory computer-readable medium, wherein a computer program is stored in the computer-readable storage medium (“one or more non-transitory computer-readable media”; paragraph [0014]; Figure 6), and when the computer program is run on a computer, the computer is enabled to perform operations (“computer-executable instructions for performing a method”; paragraph [0014]; Figure 6), comprising determining a current measurement environment and/or measurement target (“determining a motion status of the user”; paragraph [0014]; Figure 6), wherein the measurement environment comprises at least one of motion, rest, and sleep (“exercise, light motion (e.g., walking), no motion or rest, sleep”; paragraph [0124]; Figure 6), and the measurement target comprises at least one of a heart rate and blood oxygen (“determine a heart rate of the user”; paragraph [0014]; Figure 6), and determining a light emitting mode of the light emitting module based on the current measurement environment and/or measurement target (“based on the motion status of the user, automatically and selectively activate one or more of the light emitters to determine a heart rate of the user”; paragraph [0012]; “The processing module may adjust the duty cycle of one or more light emitters and the corresponding sampling rate of the one or more light detectors based on the motion status. For example, upon determining that the motion status indicates that the user is at a first higher level of motion, the processing module may activate the light emitters at a first higher duty cycle and sample the reflected light using light detectors sampling at a first higher sampling rate”; paragraph [0125]; Figure 6). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 2, 14, 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Ahmed as applied to claim 1 above, and further in view of US 2020/0054219 A1 (hereinafter referred to as “Ni”) and US 2010/0324386 A1 (hereinafter referred to as “Moon”) Regarding claim 2, 14, and 18, Ahmed further teaches that the light emitting module comprises at least one light emitting device (“a plurality of light emitters”; paragraph [0012]; Figure 6), and determining the light emitting mode of the light emitting module based on the current measurement environment (“automatically and selectively activate one or more of the light emitters”; paragraph [0012]; Figure 6). Ahmed does not explicitly teach determining the light emitting mode of the light emitting module based on the measurement target and enabling at least one light emitting device to emit green light when the measurement target is a heart rate. However, Ni teaches determining the light emitting mode of the light emitting module based on the measurement target (paragraph [0060]; Figure 3), and enabling at least one light emitting device to emit green light when the measurement target is a heart rate (paragraph [0060]; Figure 3). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Ahmed to select Ni’s green emitter for heart-rate measurement because Ni teaches that green light is used for heart-rate detection and would have predictably enabled Ahmed’s wearable PPG system to perform the selected physiological measurement using the known optical mode for that measurement. Further, Moon teaches enabling at least one light emitting device to alternately emit red light and infrared light when the measurement target is blood oxygen (“During a measurement of SpO2, both the red and infrared LEDs are alternately driven with separate current pulses”; paragraph [0119]; Figure 20). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Ahmed, in view of Ni, to use Moon’s alternating red and infrared illumination for blood-oxygen measurement because doing so allows for the measurement of oxygen saturation and would have predictably enabled Ahmed’s wearable PPG system to perform the selected physiological measurement using the known optical mode for that measurement. Regarding claims 5, 17, and 21, Ahmed further teaches that the light emitting module comprises at least one light emitting device (“a plurality of light emitters”; paragraph [0012]; Figure 6). Ahmed does not explicitly teach determining the light emitting mode based on the measurement target; selecting the light-emitting device when the measurement target is blood oxygen; and enabling at least one light emitting device to alternately emit red light and infrared light when the measurement target is blood oxygen. However, Ni teaches determining the light emitting mode based on the measurement target (“For blood oxygen detection”; paragraph [0060]; Figure 3), and selecting the light-emitting device when the measurement target is blood oxygen (“the red/infrared (R/IR) LED is started”; paragraph [0060]; Figure 3). It would have been obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Ahmed for selecting the light-emitting device when the measurement target is blood oxygen, as taught by Ni, because doing so allows a user to selectively choose the appropriate emitters for measuring oxygen saturation. Further, Moon teaches enabling at least one light emitting device to alternately emit red light and infrared light when the measurement target is blood oxygen (“both the red and infrared LEDs are alternately driven”; paragraph [0119]; Figure 20). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Ahmed, in view of Ni, to use Moon’s alternating red and infrared illumination for blood-oxygen measurement because doing so allows for the measurement of oxygen saturation and would have predictably enabled Ahmed’s wearable PPG system to perform the selected physiological measurement using the known optical mode for that measurement. Claim(s) 3-4, 8, 15-16, and 19-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Ahmed as applied to claims 1, 7, 12, and 13 above, and further in view of US 2016/0029898 A1 (hereinafter referred to as “LeBoeuf”). Regarding claim 3, 15, and 19,Ahmed further teaches that the light emitting module comprises a plurality of light emitting devices (“a plurality of light emitters”; paragraph [0012]; Figure 6), and determining the light emitting mode based on the measurement environment by selectively activating one or more light-emitting devices (“based on the motion status of the user, automatically and selectively activate one or more of the light emitters to determine a heart rate of the user”; paragraph [0012]; Figure 6). Ahmed does not explicitly teach enabling a first number of the light emitting devices when the measurement environment is motion, enabling a second number of the light emitting devices when the measurement environment is rest or sleep, and the first number is greater than the second number. However, LeBoeuf teaches enabling a first number of the light emitting devices when the measurement environment is motion (paragraph [0108]; Figure 7A), enabling a second number of the light emitting devices when the measurement environment is rest or sleep paragraph [0108]; Figure 7A), and the first number is greater than the second number (paragraph [0108]; Figure 7A). It would have been obvious to one of ordinary skill in the art to modify Ahmed’s environment-dependent emitter selection to use LeBoeuf’s greater number of active emitters during motion and smaller number of active emitters during rest or sleep because doing so conserves power during low activity. Regarding claim 4, 16, and 20, Ahmed teaches that the light emitting module comprises at least one light emitting device (“a plurality of light emitters”; paragraph [0012]; Figure 6), and determining the light emitting mode based on the measurement environment by changing the emitted wavelength (“the frequency or wavelength of light emitted by the light emitters”; paragraph [0123]; Figure 6). Ahmed does not explicitly teach enabling at least one light emitting device to emit visible light when the measurement environment is motion or rest, or enabling at least one light emitting device to emit infrared light when the measurement environment is sleep. However, LeBoeuf teaches enabling at least one light emitting device to emit visible light when the measurement environment is motion or rest (“visible (such as green or yellow) wavelengths”; paragraph [0087]), or enabling at least one light emitting device to emit infrared light when the measurement environment is sleep (“shift from visible...wavelengths to infrared wavelengths”; paragraph [0087]; paragraph [0088]). It would have been obvious to modify Ahmed’s activity-dependent wavelength control to use LeBoeuf’s method of using visible illumination during waking motion or rest and infrared illumination during sleep because doing so avoids visible-light disturbance during sleep and supports reduced-power operation during sleep. Regarding claim 8, Ahmed teaches wherein the first sampling rate is 100 Hz (“about 100 Hz”; paragraph [0126]; Figure 6). Ahmed does not explicitly teach wherein the second sampling rate is 25 Hz. However, LeBoeuf teaches wherein the second sampling rate is 25 Hz (“25 Hz for a heart rate calculation during low physical activity”; paragraph [0121]; Figures 21A–21B). It would have been obvious to one of ordinary skill in the art to select Ahmed’s disclosed 100 Hz sampling rate as the first, higher sampling rate during motion and LeBoeuf’s disclosed 25 Hz sampling rate as the second, lower sampling rate during rest or sleep because doing so reduces power consumption during lower-activity conditions. Claim(s) 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Ahmed as applied to claim 1 above, and further in view of Ni. Regarding claim 6, Ahmed teaches further teaches that the light emitting module comprises at least one light emitting device including a plurality of separately controllable light emitters (“a plurality of light emitters”; paragraph [0012]; Figure 6), selecting one or more light emitters based on the measurement environment (“automatically and selectively activate one or more of the light emitters”; paragraph [0012]; Figure 6), adjusting the number of active light emitters based on motion status (“the number of light emitters activated”; paragraph [0123]; Figure 6), and adjusting the wavelength emitted based on motion status (“the frequency or wavelength of light emitted”; paragraph [0123]; Figure 6). Ahmed does not explicitly teach enabling the first light emitting device and the second light emitting device to emit green light when the measurement target is a heart rate; However, Ni teaches first and second light emitting devices capable of emitting green light (“two sets of green LEDs”; paragraph [0062]; Figure 5A), when the measurement target is a heart rate (paragraph [0060]; Figure 3). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Ahmed which already teaches adjusting emitters based on motion, to select Ni’s green emitter for heart-rate measurement because Ni teaches that green light is used for heart-rate detection and would have predictably enabled Ahmed’s wearable PPG system to perform the selected physiological measurement using the known optical mode for that measurement. Allowable Subject Matter Claims 9, and claims dependent thereof, are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Regarding claim 9, the prior art does not teach or suggest “determining an integration time of the PPG module based on the current measurement environment, and using a first integration time when the measurement environment is motion; or using a second integration time when the measurement environment is rest or sleep, wherein the first integration time is greater than the second integration time” in combination with the other limitations of the claim upon which it depends. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ABID A MUSTANSIR whose telephone number is (408)918-7647. The examiner can normally be reached M-F 10 am to 6 pm Pacific Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason Sims can be reached at 571-272-7540. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ABID A MUSTANSIR/ Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Mar 08, 2023
Application Filed
Aug 05, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702349
SYSTEMS AND METHODS FOR MONITORING AND TREATING DIABETIC FOOT ULCERS
4y 8m to grant Granted Aug 11, 2026
Patent 12685463
IMPROVED PPG MEASUREMENT
4y 0m to grant Granted Jul 21, 2026
Patent 12685464
TRANSABDOMINAL FETAL OXIMETRY BASED ON FREQUENCY-MODULATED CONTINUOUS-WAVE NEAR-INFRARED SPECTROSCOPY
3y 3m to grant Granted Jul 21, 2026
Patent 12678077
PERFORMING MEASUREMENTS USING SENSORS OF A MEDICAL DEVICE SYSTEM
2y 4m to grant Granted Jul 14, 2026
Patent 12667281
METHOD FOR MONITORING A RECUMBENT PATIENT TO OBTAIN INFORMATION ON A BODY POSITION OF THE PATIENT
4y 5m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
90%
With Interview (+11.8%)
2y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 465 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month